Immunovant Inc (IMVT) returns
Immunovant returns over 5 years
$1,000 invested in Immunovant five years ago was worth $3,628 at the close on October 30, 2026, with dividends reinvested: an average return of 29.4% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -13.6% | — | $863.53 | -0.9% |
| 3 months | -26.1% | — | $738.86 | +2.1% |
| Year to date | +14.8% | — | $1,148 | +11.7% |
| 1 year | +17.5% | — | $1,175 | +12.4% |
| 3 years | -11.4% | -4.0% | $886.09 | +88.5% |
| 5 years | +262.8% | +29.4% | $3,628 | +76.0% |
Immunovant return by calendar year
| Year | IMVT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +14.8% | +11.7% | +3.1% |
| 2025 | +2.6% | +17.7% | -15.1% |
| 2024 | -41.2% | +24.9% | -66.1% |
| 2023 | +137.4% | +26.2% | +111.2% |
| 2022 | +108.3% | -18.2% | +126.5% |
| 2021 | -81.6% | +28.7% | -110.3% |
| 2020 | +191.1% | +18.4% | +172.7% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Immunovant Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.